LSE:HIK (Hikma Pharmaceuticals PLC)
About HIK
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Hikma Pharmaceuticals PLC (LSE: HIK) Latest News

Investing
This FTSE 100 stock looks good to me and I’d consider buying it now

Investing Articles
After earnings, is the Hikma Pharmaceuticals share price due a bounce?

Investing Articles
The UK stock market is brimming with hidden value. Here are some top picks to consider in July

Investing Articles
I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April

Investing Articles
2 FTSE 100 shares investors should consider buying for a winning portfolio

Investing Articles
£9,000 in excess savings? I’d buy 457 shares of this dividend stock to target a £1,100 extra income

Investing Articles
These were the best performers on the FTSE 100 in January

Investing Articles
I reckon this FTSE 100 stock, around 35% below its high, is cheap and growing fast!

Investing Articles
Can this FTSE 100 stock grow 2x in 2 years?

Investing Articles
Is the Hikma Pharmaceuticals share price becoming cheap?

Investing Articles
Is this FTSE pharma stock a no-brainer buy?
